Effects of Systolic Pulmonary Arterial Pressure on Long-Term Mortality in Patients with Chronic Obstructive Pulmonary Disease and TAVI Effects of Systolic Pulmonary Artery Pressure in Patients with Lung Disease and TAVI
Article Sidebar
Main Article Content
Abstract
Objective: Previous studies have shown that the presence of chronic obstructive pulmonary disease (COPD) has an effect on negative mortality and morbidity in transcatheter aortic valve implantation (TAVI) patients, the effect of systolic pulmonary artery pressure (sPAP) on long-term mortality in these patients has not been investigated. In this study, we planned to investigate the effect of sPAP on long-term mortality in patients with known COPD who were scheduled for TAVI.
Methods: In this retrospective study, a total of 72 patients diagnosed with COPD and undergoing TAVI were included. Patients were divided into 2 groups based on their baseline sPAP values as for both cut off values of 34 mmhg 46 mmhg respectively [normal (sPAP <34 mmHg) and moderate-to-severe (sPAP ≥34 mmHg); 46 mmhg the cut-off value defined as the predictive value of mortality with the roc curve]. Transthoracic echocardiography parameters were used for sPAP evaluation. The primary endpoint was determined as 5-year mortality.
Results: When comparing the groups based on their 5-year mortality, it was observed that sPAP values were significantly higher in the mortality group (p < 0.001). In addition, when patients were classified according to sPAP groups, 5-year mortality was found to be significantly higher in patients with sPAP ≥34 mmHg (<0.001) and sPAP ≥46 mmHg (p<0.001).
Conclusion: The most significant outcome derived from our study is that elevated sPAP values measured solely through echocardiography serve as a crucial indicator of in-hospital and 5-year mortality risk among TAVI patients previously diagnosed with COPD.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2023-08-21
Published 2023-08-23
References
Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137(1):82-90. doi:10.1016/j.jtcvs.2008.08.015
Zlotnick DM, Ouellette ML, Malenka DJ, et al. Effect of preoperative pulmonary hypertension on outcomes in patients with severe aortic stenosis following surgical aortic valve replacement. Am J Cardiol. 2013;112(10):1635-1640. doi:10.1016/j.amjcard.2013.07.025
Ferguson TB Jr, Dziuban SW Jr, Edwards FH, et al. The STS National Database: current changes and challenges for the new millennium. Committee to Establish a National Database in Cardiothoracic Surgery, The Society of Thoracic Surgeons. Ann Thorac Surg. 2000;69(3):680-691. doi:10.1016/s0003-4975(99)01538-6
Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16(1):9-13. doi:10.1016/s1010-7940(99)00134-7
Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607. doi:10.1056/NEJMoa1008232
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374(17):1609-1620. doi:10.1056/NEJMoa1514616
Tokarek T, Sobczyński R, Dziewierz A, et al. Clinical outcomes in patients after surgical and transcatheter aortic valve replacement. Pol Arch Med Wewn. 2015;125(10):755-764. doi:10.20452/pamw.3117
Liao YB, He ZX, Zhao ZG, et al. The relationship between chronic obstructive pulmonary disease and transcatheter aortic valve implantation--A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2016;87 Suppl 1:570-578. doi:10.1002/ccd.26443
Mok M, Nombela-Franco L, Dumont E, et al. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes. JACC Cardiovasc Interv. 2013;6(10):1072-1084. doi:10.1016/j.jcin.2013.06.008
Chopard R, Meneveau N, Chocron S, et al. Impact of chronic obstructive pulmonary disease on Valve Academic Research Consortium-defined outcomes after transcatheter aortic valve implantation (from the FRANCE 2 Registry). Am J Cardiol. 2014;113(9):1543-1549. doi:10.1016/j.amjcard.2014.01.432
Hayes D Jr, Black SM, Tobias JD, Mansour HM, Whitson BA. Prevalence of Pulmonary Hypertension and its Influence on Survival in Patients With Advanced Chronic Obstructive Pulmonary Disease Prior to Lung Transplantation. COPD. 2016;13(1):50-56. doi:10.3109/15412555.2015.1043425
Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Hirth C, Roegel E. Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1984;130(6):993-998. doi:10.1164/arrd.1984.130.6.993
Gupta NK, Agrawal RK, Srivastav AB, Ved ML. Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease. Lung India. 2011;28(2):105-109. doi:10.4103/0970-2113.80321
Gupta KK, Roy B, Chaudhary SC, et al. Prevalence of pulmonary artery hypertension in patients of chronic obstructive pulmonary disease and its correlation with stages of chronic obstructive pulmonary disease, exercising capacity, and quality of life. J Family Med Prim Care. 2018;7(1):53-57. doi:10.4103/jfmpc.jfmpc_18_17
Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127(5):1531-1536. doi:10.1378/chest.127.5.1531
Portillo K, Torralba Y, Blanco I, et al. Pulmonary hemodynamic profile in chronic obstructive pulmonary disease [published correction appears in Int J Chron Obstruct Pulmon Dis. 2015;10:2377]. Int J Chron Obstruct Pulmon Dis. 2015;10:1313-1320. Published 2015 Jul 14. doi:10.2147/COPD.S78180
Higham MA, Dawson D, Joshi J, Nihoyannopoulos P, Morrell NW. Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. Eur Respir J. 2001;17(3):350-355. doi:10.1183/09031936.01.17303500
Aguirre-Franco, C., et al. "Prevalence of pulmonary hypertension in COPD patients living at high altitude." Pulmonology (2022).
Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 2012;42(5):S45-S60. doi:10.1093/ejcts/ezs533
Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67-119. doi:10.1093/eurheartj/ehv317
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-470. doi:10.7326/0003-4819-130-6-199903160-00002
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes- 2018. Diabetes Care. 2018; 41: S13-S27.
Rodés-Cabau J, Webb JG, Cheung A, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60(19):1864-1875. doi:10.1016/j.jacc.2012.08.960
Aras MA, Psotka MA, De Marco T. Pulmonary Hypertension Due to Left Heart Disease: an Update. Curr Cardiol Rep. 2019;21(7):62. Published 2019 May 27. doi:10.1007/s11886-019-1149-1
Dziewierz A, Tokarek T, Kleczynski P, et al. Impact of chronic obstructive pulmonary disease and frailty on long-term outcomes and quality of life after transcatheter aortic valve implantation. Aging Clin Exp Res. 2018;30(9):1033-1040. doi:10.1007/s40520-017-0864-y